Last update :
05/12/2025
General anesthetic   Esketamine  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Eskesia Austria, Belgium, Croatia, Denmark, Finland, France, Germany, Great Britain, Iceland, Ireland, Luxembourg, Norway, Sweden, Switzerland
Ketanest Austria, Finland, Germany, Norway, Poland, Sweden
Vesierra Belgium, Great Britain, Luxembourg
References   injection   References : Esketamine  
Type Publication
4664 Journal Harder M, Fiegl-Lechner A, Oberacher H, Horvath U.E.I, Schlager A, Jeske M, Kerndler S, Schüllner F, Bonn G.F, Rainer M.
Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care.
Biomed Chromatogr 2022 ;e5340.
4700 Manufacturer Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics
AS Kalceks 2022
4851 Journal Kinet-Poleur A, Colsoul M.L, Catry E, Bihin B, Sneyers B, Hubert J, Jamart J, Soumoy L, Galanti L,Hecq J-D, Closset M.
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C.
EJHP 2024

  Mentions Légales